InvestorsHub Logo
Followers 3179
Posts 208744
Boards Moderated 2
Alias Born 02/04/2004

Re: Wrinkles post# 12037

Monday, 07/13/2015 8:39:01 AM

Monday, July 13, 2015 8:39:01 AM

Post# of 38634
Wow considering last year they were under the exclusivity protection phase, that's some pretty sweet FocalinXR revenue to see as they barely lost any market share despite losing their exclusivity>>>

Revenue related to the Company's license and commercialization agreement with Par Pharmaceutical, Inc. ("Par") in the three months ended May 31, 2015 was $1.2 million versus $1.4 million in the three months ended May 31, 2014

Love the trend not the stock - If you fail to plan your trades you plan to fail

My posts are just my own opinion!